Thai HIV Vaccine Hype Misrepresents Data; AHF Calls for Independent Review of AIDS Vaccine Effort Business Wire
click here to return to Business Wire main menu
DonateNow





Thai HIV Vaccine Hype Misrepresents Data; AHF Calls for Independent Review of AIDS Vaccine Effort

Business Wire - October 12, 2009


LOS ANGELES - AIDS Healthcare Foundation (AHF), the largest non-profit HIV/AIDS healthcare provider in the US which now provides treatment and services for more than 110,000 individuals in 21 countries worldwide in the US, Africa, Latin America/Caribbean and Asia, expressed frustration and disappointment at the news that data that seriously undermines a widely reported Thai HIV vaccine trial were not released publicly when other, more favorable data from the vaccine trial were publicly reported late last month. The release of only partial--and favorable--data, which showed initial efficacy in approximately one third of the Thai vaccine trial participants, led to worldwide favorable publicity for the thought-to-be-promising vaccine effort, which was conducted by researchers from the US Army and Thailand.

According to the Wall Street Journal (Oct. 10-11, 2009), a second heretofore suppressed or previously unreleased analysis of data from the same Thai vaccine trial suggested that the "modest protection highlighted by researchers might be a statistical fluke." The Journal reported that the additional data were available to the US and Thai researchers on September 24th when they announced the trial results to worldwide acclaim, but they chose not to release them. WSJ also noted,

"The incomplete disclosure raises the question of whether the Army, the Thai government and the U.S. National Institutes of Health--which helped fund the study--rushed to give a positive spin to what may turn out to be another inconclusive AIDS-vaccine effort."

"Following the repeated failures in AIDS vaccine research over the years, the premature and partial reporting of select--and favorable--vaccine trial data here underscores an inherent and glaring conflict of interest: Researchers working on NIH-funded vaccine trials may be tempted to try to show successful outcomes regardless of what the data may actually show in order to maintain or increase NIH funding for continuing research," said Michael Weinstein, President of AIDS Healthcare Foundation. "What is needed is rigorous review and evaluation of such vaccine trial data by an independent outside body. For NIH-funded scientists or US government researchers to also evaluate and discuss the significance of their own research is akin to allowing students to grade their own papers. Data can be cherry-picked; more so, if there is an incentive for future or increased government research funding based on today's thought-to-be 'promising' outcomes."

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation (AHF) is the nation's largest non-profit HIV/AIDS healthcare provider. AHF currently provides medical care and/or services to more than 110,000 individuals in 21 countries worldwide in the US, Africa, Latin America/Caribbean and Asia. Additional information is available at www.aidshealth.org.

Contacts

AIDS Healthcare Foundation

Media Contact:

Ged Kenslea, 323-860-5225

Mobile: 323-791-5526

gedk@aidshealth.org

or

Alternate Media Contact:

Lori Yeghiayan, 323-860-5227

Mobile: 323-377-4312

lori.yeghiayan@aidshealth.org


091012
BW091012


Copyright © 2009 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .